1. Home
  2. CLMT vs STOK Comparison

CLMT vs STOK Comparison

Compare CLMT & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calumet Specialty Products Partners L.P. Common Units

CLMT

Calumet Specialty Products Partners L.P. Common Units

HOLD

Current Price

$19.57

Market Cap

1.7B

Sector

Energy

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$30.99

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLMT
STOK
Founded
1916
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
CLMT
STOK
Price
$19.57
$30.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
9
Target Price
$20.45
$31.00
AVG Volume (30 Days)
740.4K
946.2K
Earning Date
11-07-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.68
Revenue
$4,048,000,000.00
$205,632,000.00
Revenue This Year
$0.16
$430.24
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$45.22
Revenue Growth
N/A
1128.17
52 Week Low
$7.68
$5.35
52 Week High
$23.75
$38.69

Technical Indicators

Market Signals
Indicator
CLMT
STOK
Relative Strength Index (RSI) 58.81 59.84
Support Level $18.99 $28.74
Resistance Level $19.80 $31.44
Average True Range (ATR) 0.69 1.88
MACD 0.08 0.34
Stochastic Oscillator 92.25 92.30

Price Performance

Historical Comparison
CLMT
STOK

About CLMT Calumet Specialty Products Partners L.P. Common Units

Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: